Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression
Lobna Ibrahim, Nancy Diazgranados, David A Luckenbaugh, Rodrigo Machado-Vieira, Jacqueline Baumann, Alan G Mallinger, Carlos A Zarate Jr, Lobna Ibrahim, Nancy Diazgranados, David A Luckenbaugh, Rodrigo Machado-Vieira, Jacqueline Baumann, Alan G Mallinger, Carlos A Zarate Jr
Abstract
Background: Ketamine rapidly improves depressive symptoms in patients with treatment-resistant major depressive disorder (MDD) who do not respond to multiple standard antidepressants. However, it remains unknown whether ketamine is equally effective in patients with MDD who previously also did not respond to electroconvulsive therapy (ECT).
Methods: This study compared 17 patients with treatment-resistant MDD who previously did not respond to ECT and 23 patients with treatment-resistant MDD who had not previously received ECT. All subjects received a single open-label infusion of ketamine (0.5 mg/kg). Patients were evaluated using the Montgomery-Asberg Depression Rating Scale (MADRS) at baseline (60 min before the infusion), as well as at 40, 80, 120, and 230 min after infusion.
Results: Depressive symptoms were significantly improved in the ECT-resistant group at 230 minutes with a moderate effect size (p < .001, d = 0.50, 95% C.I.: 0.21-0.80). At 230 minutes, the non-ECT exposed group showed significant improvement with a large effect size (p < .001, d=1.00, 95% C.I.: 0.71-1.29).
Conclusion: Ketamine appears to improve depressive symptoms in patients with MDD who had previously not responded to ECT. These preliminary results encourage further investigation with a larger sample size to determine effectiveness compared to other treatment-resistant patients with MDD.
Published by Elsevier Inc.
Figures


Source: PubMed
Kommende kliniske forsøg
-
University of LahoreIkke rekrutterer endnuKardiometaboliske tilstandePakistan
-
Beijing Tiantan HospitalIkke rekrutterer endnuAcute and Chronic Postsurgical Pain
-
Instituto de Investigación Sanitaria de la Fundación...RekrutteringVaskulær adgang | Vaskulær adgangskomplikation | Vaskulær adgangsudstyrSpanien
-
Liverpool John Moores UniversityRekrutteringHypoxi | Koffein | Placebo - kontrolDet Forenede Kongerige
-
Democritus University of ThraceRekrutteringFeasibility of Occupation-Based Immersive Virtual Reality for Upper-Limb Rehabilitation After StrokeSlag | Parese i øvre ekstremitetGrækenland
-
Cedars-Sinai Medical CenterIkke rekrutterer endnuPreterm Prelabor Rupture of Membranes (PPROM)Forenede Stater
-
Zheng LiIkke rekrutterer endnuKognitiv skrøbelighed
-
Gwangju Health UniversityRekrutteringUng voksen | Kronisk ankelinstabilitet, CAISydkorea
-
Hospital Universitari Joan XXIII de Tarragona.Institut Investigacio Sanitaria Pere VirgiliIkke rekrutterer endnuKnæ slidgigt | Kroniske knæsmerterSpanien
-
HealthPartners InstituteRekrutteringMild traumatisk hjerneskade | Hjernerystelse (diagnose)Forenede Stater
-
Fudan UniversityIkke rekrutterer endnu